A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adult Subjects

NCT04551573 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped COVID-19 Pandemic

Conditions

Tuberculosis
Hiv

Interventions

DRUG: Rifapentine daily
DRUG: Rifapentine weekly

Sponsor

Yale University

Collaborators

[object Object]